Area of research
Toxicology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Medicine, Pharmacovigilance, Drug, Adverse Event Reporting System, Adverse effect, and Pharmacology.
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People
SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region
Pharmacovigilance assessment of the association between Fournier’s gangrene and other severe genital adverse events with SGLT-2 inhibitors
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System
Pro-Arrhythmic Potential of Oral Antihistamines (H1): Combining Adverse Event Reports with Drug Utilization Data across Europe
Torsadogenic Risk of Antipsychotics: Combining Adverse Event Reports with Drug Utilization Data across Europe
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones